Results 121 to 130 of about 436,550 (248)

EL ARTISTA RESPONSABLE Y EL ARTISTA MELANCÓLICO [PDF]

open access: yes, 2008
En 1982 y en carta a Thomas E. Carroll, Jean-François Lyotard ensayaba una de sus explicaciones a los niños, intentos de responder al revuelo provocado por aquella Condición postmoderna publicada en 19791. La aclaración de Lyotard empezaba por definir la
Corella Lacasa, Miguel
core   +3 more sources

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort   +8 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Amoxicillin, a widely used β‐lactam antibiotic, requires improved pharmacokinetic characterization during breastfeeding. This study used a population pharmacokinetic (PopPK) approach to model amoxicillin concentrations in breast milk, identify variability sources and estimate infant exposure, applying worst‐case scenarios.
Sarah Baklouti   +9 more
wiley   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Dexamethasone versus 5-HT3 receptor antagonists in preventing nausea during awake craniotomy: a propensity score matching study

open access: yesJA Clinical Reports
Background Nausea and vomiting during awake craniotomy (AC) can increase cerebral pressure and cause asphyxia and aspiration. 5-HT3 receptor antagonists, such as granisetron, are often administered before awakening to prevent nausea during AC.
Takehito Sato
doaj   +1 more source

“ONDANSETRON VERSUS PALONOSETRON PARA EL MANEJO DE NÁUSEA Y VÓMITO POSTOPERATORIO EN COLECISTECTOMÍA LAPAROSCÓPICA EN ISSEMYM SATÉLITE” [PDF]

open access: yes, 2013
Antecedentes: Las náuseas y vómitos postoperatorios (NVPO) son de los mayores problemas en anestesia, con una alta incidencia en cirugía laparoscópica.
Márquez Zapien, Cuitláhuac   +1 more
core  

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

PLANEACIÓN DIDÁCTICA GENERAL DE LA ASIGNATURA: FILOSOFÍA CONTEMPORÁNEA [PDF]

open access: yes, 2018
GUÍA DIDÁCTICA / PLANEACIÓN DIDÁCTICA ...
ARRAZOLA VEGA MITZI NAZARETH   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy